Barcelona snapshots

Continuing Education Program

Hospitals & Universities


Complement your educational schedule by suggesting your alumni or residents/trainees the talks on a REGULAR and PLANNED basis during the academic year.

We propose thematically ordered contents provided by some of the best world specialists in their field. The talks have been selected from the Symposiums of the 2021, 2020, 2019, 2018, 2017 and 2016 editions (85 talks).

This Continuing Education Program offers very substantial packaged discounts for professional training programs.

GOALS: To bring our excellent speakers and content -of the highest international level- to training specialists and to do so at a very affordable cost.

AUDIENCE: Available for PSYCHIATRY TRAINEES, RESEARCHERS, PROFESSORS and STUDENTS (PhD, postgraduate or undergraduate) of mental health educational or training programs.

FORMAT: HD video streaming talks in English language.

- Prof. Guy Goodwin, University of Oxford, UK.
- Title: "Cognitive symptoms as a target for treatment of depression"
- Bio, abstract, and references available at: BIO & ABSTRACT


We thematically highlight the following talks, from the available 85 talks of the 2021, 2020, 2019, 2018, 2017 and 2016 editions:


  • Medical comorbidities and affective disorders
    Brenda W.J.H. Penninx, Vrije Universiteit Amsterdam, Netherlands
  • Cognitive symptoms in depression
    Raymond W. Lam, University of British Columbia, Canada
  • Is a better antidepressant the answer?: the future of antidepressant pharmacotherapy beyond the monoamines
    Jerrold F. Rosenbaum, Harvard University, USA
  • New targets for treating depression: inflammation, oxidative stress and neurotrophic factors
    Michael Berk, Deakin University, Australia
  • Glutamatergic function and new approaches for treatment-resistant depression
    Sanjay Mathew, Baylor College of Medicine, USA
  • Antidepressants: refining future treatments approaches
    Catherine J. Harmer, University of Oxford, United Kingdom
  • Role of ECT for treatment-resistant affective disorders
    Colleen K. Loo, University of New South Wales, Australia


  • At risk mental states
    Alison R. Yung, University of Manchester, United Kingdom
  • Persecutory delusions
    David G. Fowler, University of Sussex, United Kingdom
  • The controversy of first episodes treatment
    Benedicto Crespo-Facorro, Universidad de Cantabria, Spain
  • Cognitive symptoms in the recovery of psychosis
    Christoph U. Correll, Hofstra University, USA
  • Long term antipsychotic treatments improve life functional prognosis
    Wolfgang Fleischhacker, Universität Innsbruck, Austria
  • The Neurobiology of Treatment Resistance: Beyond Dopamine and Persistent Psychosis
    Herbert Meltzer, Northwestern University, USA


  • Delusions: Nature approach
    Christoph U. Correll, Hofstra University, USA
  • Delusions: Nurture approach
    Jim van Os, Maastricht University, Netherlands
  • Discussion


  • Can technology unravel the complexity of mental disorders?
    Thomas R. Insel, MindStrong Health, USA
  • Digital mental health for common mental health pathologies
    David C Mohr, Northwestern University, USA
  • New hopes on physical treatments in psychiatry?
    Damiaan Denys, Universiteit van Amsterdam, Netherlands


  • Psychiatry and its neighbours
    German E. Berrios,Cambridge University, United Kingdom
  • Psychiatrization of everyday life
    Allen J. Frances, Duke University, USA
  • Discussion


  • Psychopathy: pathology or wickedness, where are the boundaries?
    Jeremy W. Coid, Queen Mary University of London, United Kingdom
  • Childhood maltreatment and treatment resistance in adult psychiatric disorders
    Carmine Pariante, King's College London, United Kingdom
  • Treatment of borderline personality disorder: Psychosocial approach
    Anthony Bateman, University College London, United Kingdom
  • Suicidal behaviour: understandable reaction to difficult life circumstances or preventable disorder?
    Ulrich Hegerl,Universität Leipzig, Germany
  • Prodromal features of Alzheimer’s and other neurodegenerative diseases
    John O'Brien, Cambridge University, United Kingdom
  • The social determinants of mental health and illness
    Sir Michael Marmot, University College London, United Kingdom
  • Plausible models need to integrate the Psychosocial and Biological
    Sir Robin M. Murray, King's College London, United Kingdom

Join the program

In order to register in the program and obtain more information about the DISCOUNTS as well and other useful information, a responsible of the research-group or department has to contact us.

Contact us HERE

Active entities

UAB Symposium Psychiatry Controversies Barcelona 2021